Metatron Hunter 4025 Scanning in the Diagnosis of Pancreatic Diseases

A modern NLS approach for the diagnosis of pancreatic diseases using the Metatron Hunter 4025 scanner. Based on an analysis of data from over 300 patients with pancreatic tumors (TG). Kuznetsova et al. concluded that NLS research achieved a 92.6% response rate and 98.8% specificity in 3D modeling for pancreatic cancer diagnosis. Comparing the information levels of 3D NLS and CT, NLS-research showed a response rate of 89.7% and a specificity of 98.0% in diagnosing pancreatic head cancer, while CT showed a response rate of 85.7% and a specificity of 87.1%. The modern approach of NLS scanning—ultramicroscopic scanning, spectral entropy analysis, and 3D reconstruction of organs—allows the collection of additional information about tumor structure, the extent of retropancreatic vessels, and lymph node involvement in the pathological process, which is useful for planning surgical interventions. NLS with superscanning and SEA achieves an accuracy of 89–98% in detecting tumor invasion in pancreatic cancer.

Modern methods of NLS scanning—supermicroscopy, spectral entropy analysis, and 3D reconstruction of the organ—allow for the collection of additional information about tumor structure, the extent of retropancreatic vessels, and lymph node involvement in the pathological process, which is useful for planning surgical interventions. NLS with superscanning and SEA achieves an accuracy of 89–98% in detecting tumor invasion in pancreatic cancer.

Comparative analysis of plain NLS data and supermicroscopy versus SEA data demonstrates the undeniable advantage of the new technique in representing pancreatic structures. Using superscanning, we were able to determine the boundaries of tumor invasion and visualize the solid and cystic components of the mass occupying the pancreatic parenchyma. We should emphasize the high informational value of the new technique in revealing cystic structures. This diagnosis becomes very easy and comfortable for therapists due to the appropriate study of fluid components. Another important advantage of the new NLS technique is the visualization of affected retropancreatic and intrapancreatic vessels. Scanning in NLS-microangiography mode provides precise information about the microvascularization status of the pancreatic parenchyma. The application of 3D reconstruction yields accurate spatial images of the vessels, including those within placeholders. In SEA applications, the differential diagnosis between pancreatic cancer and pseudotumor-like pancreatitis is highly reliable. The promising future of new NLS technology involves simultaneously acquiring multidimensional images of the glandular parenchyma and vessels. Virtual procedures facilitate the forward-looking delivery of high-quality 3D images of any scale.

Therefore, the computed Metatron Hunter 4025 technique conceptually provides new diagnostic information for patients with pancreatic masses. The results establish the NLS approach as the "gold standard" for pancreatic cancer, in comparison to CT, particularly in the context of kidney cancer.